Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaberg TM (1986) Stargardt’s disease and fundus flavimaculatus: evaluation of morphologic progression and intrafamilial co-existence. Trans Am Ophthalmol Soc 84:453–487
Allikmets R et al (1997) A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 15:236–246
Armstrong JD et al (1998) Ophthalmology 105:448–458
Beharry S, Zhong M, Molday RS (2004) N-Retinylidene-phosphatidylethanolamine is the preferred retinoid substrate for the photoreceptorspecific ABC transporter ABCA4 (ABCR). J Biol Chem 52:53972–53979
Birnbach CD et al (1994) Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology 101:1211–1219
Blacharski PA (1988) Fundus flavimaculatus. In: Newsome DA (ed) Retinal dystrophies and degenerations. Raven, New York, pp 135–159
Bonnin P (1971) Le signe du silence choroidien dans les degenerescences tapeto-retiniennes centrales examinees sous fluoresceine. Bull Soc Ophthalmol Fr 71:1423–1427
Briggs CE et al (2001) Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration. Invest Ophthalmol Vis Sci 42:2229–2236
Bungert S, Molday LL, Molday RS (2001) Membrane topology of the ATP binding cassette transporter ABCR and its relationship to ABC1 and related ABCA transporters: identification of N-linked glycosylation sites. J Biol Chem 276:23539–23546
Carr RE (1965) Fundus flavimaculatus. Arch Ophthalmol 74:163–168
De Laey JJ, Verougstraete C (1995) Hyperlipofuscinosis and subretinal fibrosis in Stargardt’s disease. Retina 15:399–406
Del Buey ME et al (1993) Posttraumatic reaction in a case of fundus flavimaculatus with atrophic macular degeneration. Ann Ophthalmol 25:219–221
Delori FC et al (1995) In vivo measurement of lipofuscin in Stargardt’s disease-Fundus flavimaculatus. Invest Ophthalmol Vis Sci 36:2327–2331
Eagle RCJ et al (1980) Retinal pigment epithelial abnormalities in fundus flavimaculatus: a light and electron microscopic study. Ophthalmology 87:1189–1200
Eldred GE, Lasky MR (1998) Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature 361:724–726
Ergun E et al (2005) Assessment of central visual function in Stargardt’s disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci, 46:310–316
Fishman GA (1976) Fundus flavimaculatus. Arch Ophthalmol 94:2061–2067
Fishman GA et al (1987) Visual acuity loss in patients with Stargardt’s macular dystrophy. Ophthalmology 94:809–814
Fishman GA et al (1999) Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol 117:504–510
Fishman GA, Farbman JS, Alexander KR (1991) Delayed rod dark adaptation in patients with Stargardt’s disease. Ophthalmology 98:957–962
Franceschetti A. (1963) über tapeto-retinale Degenerationen im Kindesalter (Kongenitale Form (Leber), amaurotische Idiotie, rezessivegeschlechtsgebundene tapeto-retinale Degenerationen, Fundus albipunctatus cum Hemeralopia, Fundus flavimaculatus). Dritter Fortbildungskurs der Deutschen Ophthalmologischen Gesellschaft, Hamburg 1962, herausgegeben von Prof. Dr. H. Sautter., in Entwicklung und Fortschritt in der Augenheilkunde. Funke, Stuttgart, pp 107–120
Franceschetti A (1965) A special form of tapetoretinal degeneration: fundus flavimaculatus. Trans Am Acad Ophthalmol Otolaryngol 69:1048–1053
Franceschetti A, Francois J (1965) Fundus flavimaculatus. Arch Ophthalmol 25:505–530
Fukui T et al (2002) ABCA4 gene mutations in Japanese patients with Stargardt’s disease and retinitis pigmentosa. Invest Ophthalmol Vis Sci 43:2819–2824
Hadden OB, Gass JDM (1976) Fundus flavimaculatus and Stargardt’s disease. Am J Ophthalmol 82:527–539
Holz FG et al (1999) Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 40:737–743
Illing M, Molday LL, Molday RS (1997) The 220-kDa rim protein of retinal rod outer segments is a member of the ABC transporter superfamily. J Biol Chem 272:10303–10310
Irvine AR, Wergeland FLJ (1972) Stargardt’s hereditary progressive macular degeneration. Br J Ophthalmol 56:817–826
Kang Derwent JJ et al (2004) Dark adaptation of rod photoreceptors in normal subjects, and in patients with Stargardt’s disease and an ABCA4 mutation. Invest Ophthalmol Vis Sci 45:2447–2456
Kaplan J et al (1993) A gene for Stargardt’s disease (fundus flavimaculatus) maps to the short arm of chromosome 1. Nat Genet 5:308–311
Klein R et al (1978) Subretinal neovascularization associated with fundus flavimaculatus. Arch Ophthalmol 96:2054–2057
Klien BA, Krill AE (1967) Fundus flavimaculatus. Clinical, functional, and histopathologic observations. Am J Ophthalmol 64:3–23
Leveille AS, Morse PH, Burch JV (1982) Fundus flavimaculatus and subretinal neovascularization. Ann Ophthalmol 14:331–334
Lewis RA et al (1999) Genotype/phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt’s disease. Am J Hum Genet 64:422–434
Lois N et al (1999) Reproducibility of fundus autofluorescence measurements obtained using a confocal scanning laser ophthalmoscope. Br J Ophthalmol 83:276–279
Lois N et al (1999) Intrafamilial variation of phenotype in Stargardt macular dystrophy—fundus flavimaculatus. Invest Ophthalmol Vis Sci 40:2668–2675
Lois N et al (2000) Quantitative evaluation of fundus autofluorescence “in vivo” in eyes with retinal disease. Br J Ophthalmol 84:741–745
Lois N et al (2001) Phenotypic subtypes of Stargardt macular dystrophy—fundus flavimaculatus. Arch Ophthalmol 119:359–369
Lois N et al (2004) Fundus autofluorescence in Stargardt macular dystrophy—fundus flavimaculatus. Am J Ophthalmol 138:55–63
Mata NL, Weng J, Travis GH (2000) Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci USA 97:7154–7159
McDonnell PJ et al (1986) Fundus flavimaculatus without maculopathy. A clinicopathologic study. Ophthalmology 93:116–119
Molday LL, Rabin AR, Molday RS (2000) ABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy. Nat Genet 25:257–258
Parisi V et al (2002) Altered recovery of macular function after bleaching in Stargardt’s diseasefundus flavimaculatus: pattern VEP evidence. Invest Ophthalmol Vis Sci 43:2741–2748
Parodi MB (1994) Progressive subretinal fibrosis in fundus flavimaculatus. Acta Ophthalmol 72:260–264
Querques G et al (2006) Analysis of retinal flecks in fundus flavimaculatus using optical coherence tomography. Br J Ophthalmol 90:1157–1162
Radu RA et al (2003) Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt’s macular degeneration. Proc Natl Acad Sci USA 100:4742–4747
Radu RA et al (2004) Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt’s macular degeneration. Proc Natl Acad Sci USA 101:5928–5933
Rotenstreich Y, Fishman GA, Anderson RJ (2003) Visual acuity loss and clinical observations in a large series of patients with Stargardt’s disease. Ophthalmology 110:1151–1158
Sparrow JR, Nakanishi K, Parish CA (2000) The lipofuscin fluorophore A2E mediates blue lightinduced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 41:1981–1989
Sparrow JR et al (2003) A2E-epoxides damage DNA in retinal pigment epithelial cells. Vitamin E and other antioxidants inhibit A2E-epoxide formation. J Biol Chem 278:18207–18213
Stargardt K (1909) über familiäre progressive Degeneration in der Makulagegend des Auges. Graefes Arch Klin Ophthalmol 71:534–550
Stavrou P et al (1998) Electrophysiological findings in Stargardt’s—fundus flavimaculatus. Eye 12:953–958
Sun H, Nathans J (1997) Stargardt’s ABCR is localized to the disc membrane of retinal rod outer segments. Nat Genet 17:15–16
Sun H, Nathans J (2001) ABCR, the ATP-binding cassette transporter responsible for Stargardt macular dystrophy, is an efficient target of alltrans-retinal-mediated photooxidative damage in vitro. Implications for retinal disease. J Biol Chem 276:11766–11774
Sun H, Molday RS, Nathans J (1999) Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt’s disease. J Biol Chem 274:8269–8281
Suter M et al (2000) Age-related macular degeneration. The lipofuscin component N-retinyl-Nretinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Biol Chem 275:39625–39630
Uliss AE, Moore AT, Bird AC (1987) The dark choroid in posterior retinal dystrophies. Ophthalmology 94:1423–1427
Van Meel GJ, Van Norren D (1986) Foveal densitometry as a diagnostic technique in Stargardt’s disease. Am J Ophthalmol 102:353–362
Von Rückmann A, Fitzke FW, Bird AC (1995) Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol 79:407–412
Von Rückmann A, Fitzke FW, Bird AC (1997) In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol 115:609–615
Webster AR et al (2001) An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci 42:1179–1189
Weng J et al (1999) Insights into the function of Rim protein in photoreceptors and etiology of Stargardt’s disease from the phenotype in abcr knockout mice. Cell 98:13–23
Wroblewski JJ et al (1995) Indocyanine green angiography in Stargardt’s flavimaculatus. Am J Ophthalmol 120:208–218
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lois, N. (2007). New Perspectives in Stargardt’s Disease. In: Holz, F.G., Spaide, R.F. (eds) Medical Retina. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33672-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-540-33672-3_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33671-6
Online ISBN: 978-3-540-33672-3
eBook Packages: MedicineMedicine (R0)